[Genomic and Epigenomic Abnormalities in Gliomas].

Abstract excerpt

Advances in genetic and epigenetic analyses and immunohistochemical studies involving the development of mutation-specific or histone-methylated antibodies have provided many significant findings about gliomas. Based on these findings, the WHO developed and published the classification of tumors of the central nervous system in 2016. In the classification system, molecular information was combined with...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Central Nervous System Neoplasms
• Share to Epigenomics
• Share to Genomics